Internal Medicine, Gastroenterology · Williamsville, NY
NPI
1316923253
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
60 Maple Rd, Ste 1
Williamsville, NY, 14221
Phone (716) 626-5250
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
290 services
Medicare patients, 2024
158
Average age 71
Drug cost, 2024
$762K
2,043 prescriptions
Company payments, 2025
$1,428
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter D Bloom was code 99214 (office e&m - established), 89 times for 65 patients. In total Peter D Bloom billed 290 services in 17 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 89 | 65 | $81.03 | $7,211 |
| 45385 Colonoscopy - Lesion Removal | Facility | 43 | 42 | $193.81 | $8,334 |
| 43239 Upper GI Endoscopy | Facility | 40 | 40 | $77.84 | $3,114 |
| 45380 Lower GI Endoscopy - Other | Facility | 35 | 35 | $80.44 | $2,815 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 27 | 26 | $4.20 | $113 |
| 99204 Office E&M - New | Office | 25 | 25 | $80.16 | $2,004 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 12 | 12 | $170.48 | $2,046 |
By year: 2022 $28K for 254 services; 2023 $28K for 282 services; 2024 $28K for 290 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter D Bloom prescribed most often to Medicare patients was Pantoprazole Sodium, with 376 prescriptions and refills. In total Peter D Bloom wrote 2,043 Medicare prescriptions that cost $762K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 376 | 890 | 111 | $6,390 |
| Famotidine Generic | 328 | 715 | 81 | $5,148 |
| Omeprazole Generic | 298 | 796 | 84 | $4,746 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 158 | 158 | 155 | $11K |
| Ondansetron Hcl Generic | 125 | 125 | 120 | $165 |
| Esomeprazole Magnesium Generic | 49 | 131 | 15 | $1,368 |
| Lansoprazole Generic | 47 | 83 | Under 11 | $813 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 43 | 43 | 41 | $773 |
| Loperamide Loperamide Hcl | 37 | 37 | 11 | $823 |
| Pentasa Mesalamine | 31 | 37 | Under 11 | $38K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 24 | 24 | Under 11 | $843 |
| Dicyclomine Hcl Generic | 24 | 26 | Under 11 | $189 |
| Trulance Plecanatide | 21 | 29 | Under 11 | $16K |
| Linzess Linaclotide | 20 | 40 | Under 11 | $21K |
| Lubiprostone Generic | 19 | 19 | Under 11 | $2,538 |
Brand drugs: 292 claims; generic drugs: 1,751 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter D Bloom $1,428 ($1,428 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $517.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $517 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 9 | $162 |
| Janssen Biotech, Inc. JNJ | 10 | $135 |
| Genzyme Corporation SNY | 4 | $92.09 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $82.64 |
| Pfizer Inc. PFE | 4 | $72.62 |
| Lilly USA, LLC LLY | 3 | $49.67 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $47.61 |
| Ardelyx, Inc. ARDX | 2 | $47.49 |
| QOL Medical, LLC | 1 | $37.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.